application: 11β,16α,17α,21-Tetrahydroxypregna-1,4-diene-3,20-dione (Budesonide EP Impurity A) is a metabolite of Budesonide (B689490), an anti-inflammatory agent.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
11a,16b,17,21-Tetrahydroxy-pregna-1,4-diene-3,20-dione
Dangerous GoodsCAS number:13951-70-7 molecular formula:C21H28O6
overview
compound introduction
Specs
| Chinese alias | 布地奈德水解物 | 11a和16b,17,21-四羟基孕甾-1, | ||
| English alias | 11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione | Q27289433 | NCGC00183124-01 | (11?,16?)-11,16,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione | SCHEMBL145096 | GREPAFLOXACIN HYDROCHLORIDE (MART.) | 16 | Pregna-1,4-diene-3,20-dione, 11,16,17,2 | ||
| CAS number | 13951-70-7 | molecular formula | C21H28O6 |
| molecular weight | 376.44 g/mol | Exact mass | ≥97% |
| PSA | 115.000 Ų | logp | 1.2 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
pictogram:
GHS08
Signal word:
Danger
Hazard Statement:
H373: 通过长时间或反复暴露对器官造成损害 H372: 通过长时间或反复暴露对器官造成损害 H360: 可能损害生育力或未出生的孩子 H361: 怀疑破坏生育力或未出生的孩子 H362: 可能对母乳喂养的孩子造成伤害
Statement of Preventive Measures:
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P264: 处理后要彻底洗手。 P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P263: 避免在怀孕期间/哺乳期间接触。 P203: 使用前,获取、阅读并遵守所有安全说明。 P318: 如果暴露或担心,请就医。 P319: 如果你感到不适,请寻求医疗帮助。
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 1 shareMSDS
13951-70-7 | 16ALPHA-HYDROXYPREDNISOLONE.pdf





